News Concerns mount over Biogen Alzheimer's drug FDA announces guidance to encourage development of new drugs
News Boehringer latest to axe Alzheimer's drug Company will trial BI 409306 in schizophrenia instead.
News Tysabri failure in stroke a setback for Biogen Biogen’s hopes that one of its established multiple sclerosis drugs might also help stroke sufferers have been dashed.
News Roche's MS drug Ocrevus priced in line with Novartis rival i... Drug likely to cost just under £10,000 per six-monthly injection.
News Roche's Ocrevus MS drug approved in EU Already a big hit in the US, Ocrevus set to make debut in EU.
News NHS funding for five MS drugs under threat NICE calls for further discounts on beta-interferons and Copaxone
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
